SCHEMBL24730261

SCHEMBL24730261

Clc1ccc2c(c1)-c1c(ccc3c1[nH]c1ccccc13)C2(c1ccc2ccccc2c1)c1ccc2ccccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.42
CDK4 P11802 4/20 0.41
CCND1 P24385 4/20 0.41
CCNE2 O96020 3/20 0.41
CCNE1 P24864 3/20 0.41
CDK2 P24941 3/20 0.41
CAMK2B Q13554 1/20 0.41
CAMK2G Q13555 1/20 0.41
CAMK2D Q13557 1/20 0.41
CAMK2A Q9UQM7 1/20 0.41
HTR2B P41595 1/20 0.38
HTR5A P47898 1/20 0.38
IDO1 P14902 2/20 0.36
CCNB2 O95067 1/20 0.36
PRKCG P05129 1/20 0.36
PRKCB P05771 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
PRKCA P17252 1/20 0.36
GSK3B P49841 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24730258 0.86 CCNE2 (0.43) KIF11CDK4CCND1CCNE2CCNE1
SCHEMBL24730283 0.83 CDK4 (0.46) KIF11CDK4CCND1CCNE2CCNE1
SCHEMBL24730298 0.81 CDK4 (0.43) KIF11CDK4CCND1CCNE2CCNE1
SCHEMBL26014320 0.77 CDK4 (0.47) KIF11CDK4CCND1CCNE2CCNE1
SCHEMBL22133797 0.76 KIF11 (0.44) KIF11CDK4CCND1CCNE2CCNE1
SCHEMBL24730268 0.74 CDK4 (0.44) KIF11CDK4CCND1CCNE2CCNE1
SCHEMBL16384821 0.73 CYP2A6 (0.42) CA1CA2CA4CA6CYP2A6
SCHEMBL15840171 0.73 KIF11 (0.42) KIF11CDK4CCND1CCNE2CCNE1
SCHEMBL24730286 0.72 TDO2 (0.41) KIF11CDK4CCND1CCNE2CCNE1
SCHEMBL15840146 0.72 KIF11 (0.46) KIF11CDK4CCND1CCNE2CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301184-A1 ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS THEREOF SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-09-21 US disclosed
US-20230257387-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-17 US disclosed
WO-2022213794-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT COMPRISING SAME, AND ELECTRONIC DEVICE 陕西莱特光电材料股份有限公司 2022-10-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301184-A1 ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS THEREOF OCIAD1, OCIAD2, OSTC KIF11 2584/4885CDK4 3268/4885CCND1 1456/4885
US-20230257387-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF OCIAD1, OCIAD2, EPCAM KIF11 2958/4885CDK4 1919/4885CCND1 172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.